Sign up to save your podcasts
Or
Share Episode 36: ODAC - Our Decisions Are Confusing
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 36: ODAC - Our Decisions Are Confusing
In this episode, Bernie and Anthony are joined by the Myeloma Man Dr. Manni Mohyuddin and lymphoma expert Dr. David Russler-Germain to discuss the very recent ODAC decisions on the STARGLO (glofitamab + GemOx) and AQUILA (daratumumab for smoldering multiple myeloma) trials. Did ODAC do their due diligence, or are there double standards? There is a lot to unpack in this episode!
View all episodes
By Bernard Marini, Anthony Perissinotti, et al.
4.5
3030 ratings
In this episode, Bernie and Anthony are joined by the Myeloma Man Dr. Manni Mohyuddin and lymphoma expert Dr. David Russler-Germain to discuss the very recent ODAC decisions on the STARGLO (glofitamab + GemOx) and AQUILA (daratumumab for smoldering multiple myeloma) trials. Did ODAC do their due diligence, or are there double standards? There is a lot to unpack in this episode!
More shows like WolverHeme Happy Hour
View all
Fresh Air
38,454 Listeners
The NPR Politics Podcast
25,772 Listeners
Pod Save America
87,167 Listeners
The Daily
112,065 Listeners
Up First from NPR
56,481 Listeners
OncoPharm
187 Listeners
Today, Explained
10,212 Listeners
Interesting Times with Ross Douthat
7,232 Listeners
Blood Podcast
52 Listeners
ASTCT Talks
8 Listeners
The Ezra Klein Show
15,853 Listeners
The Weekly Show with Jon Stewart
10,718 Listeners
Blood Cancer Talks
48 Listeners
Two Onc Docs
192 Listeners
The Headlines
620 Listeners